Expanding the Group and Improving Management Efficiency through Capital Alliances
First written in FY2018-Q3. 7 of 12 entries say "Advanced", first in FY2018. Latest entry: FY2026-H1.
Yamashita Health Care Holdings moved to the "Worse" side of this theme in 2026, 7 years after the typical company in this theme (2019).
2 other companies' latest entry also says "Softened".
- FY2026-H1SoftenedAnnual report
「As all shares of 株式会社イーディライト, formerly a consolidated subsidiary, were transferred, the company was excluded from the scope of consolidation. As a result, as of 30 November 2025, our group consisted of the Company and 8 consolidated subsidiaries.」
Following the transfer of all shares of イーディライト and its exclusion from consolidation, the number of consolidated subsidiaries contracted from 9 to 8, despite the trend of group expansion through capital alliances and other measures. - FY2025-H1RestatedAnnual report
「During the current interim consolidated accounting period, the Company acquired all shares of マイクロソニック株式会社 and made it a consolidated subsidiary.」
The acquisition of all shares of マイクロソニック株式会社 and its conversion into a consolidated subsidiary was reaffirmed as group expansion during the current interim consolidated accounting period. - FY2024AdvancedAnnual report
「June 2024: Acquired all shares of マイクロソニック株式会社, formerly an equity-method affiliate, and made it a consolidated subsidiary」
In June 2024, the Company acquired all shares of マイクロソニック株式会社, advancing group expansion by changing its status from an equity-method affiliate to a consolidated subsidiary. - FY2024-Q3AdvancedAnnual report
「On 19 December 2023, the Company acquired all shares of 株式会社鹿児島オルソ・メディカル, whose business is the wholesale of medical devices specializing in orthopedics, and made it a consolidated subsidiary.」
On 19 December 2023, the Company acquired all shares of 鹿児島オルソ・メディカル and advanced group expansion by making it a consolidated subsidiary. - FY2023AdvancedAnnual report
「On 25 July 2023, the Company newly made 株式会社クロスウェブ a consolidated subsidiary.」
Before the date of submission of the annual securities report, the Company acquired all shares of 株式会社クロスウェブ and made it a consolidated subsidiary, advancing group expansion. - FY2023-Q2AdvancedAnnual report
「In September 2022, we acquired shares in マイクロソニック株式会社, which develops medical equipment using ultrasound, and made the company an equity-method affiliate.」
In September 2022, the Company acquired shares in マイクロソニック, a developer of ultrasound-based medical equipment, advancing group expansion by making it an equity-method affiliate. - FY2022-Q2AdvancedAnnual report
「With respect to 株式会社イーディライト, formerly an equity-method affiliate of 山下医科器械株式会社, our principal operating company, 山下医科器械株式会社 made an in-kind dividend of all the shares it held in the company to the Company on 15 November 2021, and the Company additionally acquired shares in the company from 株式会社ＥＰＡＲＫ. As a result, the company was included in the scope of consolidation.」
For イーディライト, formerly an equity-method affiliate, the Company proceeded with group expansion by receiving an in-kind dividend of shares and additionally acquiring shares from EPARK, thereby making the company a consolidated subsidiary. - FY2021RestatedAnnual report
「Going forward, with the aim of achieving sustainable growth and maximizing the Group’s corporate value, the Company will actively invest in new business areas, including alliances with external companies, and expand its business scope.」
The policy of investing in new business fields, including alliances with external companies, and expanding the business portfolio was reaffirmed. - FY2020-Q1RestatedAnnual report
「In July this year, we entered into a capital and business alliance with an emerging medical device manufacturer developing a new infusion device. Going forward, the new business development office established within the core subsidiary will take the lead in launching a rental business for the device for medical institutions and nursing-care facilities nationwide.」
The capital and business alliance with an emerging medical device manufacturer and the policy of developing an infusion-device rental business were reaffirmed as part of the existing trend toward capital alliances and new business expansion. - FY2019AdvancedAnnual report
「In July this year, we entered into a capital and business alliance with a company developing gravity-fed infusion devices and launched a rental business for medical institutions and home healthcare providers. Going forward, we will work to develop new business models through this business.」
As part of efforts to expand the group and its businesses through a capital and business alliance, the Company announced an alliance with a gravity-fed infusion device company and the launch of a rental business. - FY2018AdvancedAnnual report
「In May of the current year, the Company acquired an equity interest in a start-up developing an injection drug and medical materials recognition system with a high degree of integration with electronic medical records, and will work with the company to promote the adoption of the system.」
In line with the policy of expanding the group through capital alliances and other measures, the Company acquired an equity interest in a startup related to electronic medical records. - FY2018-Q3First statedAnnual report
「With capital alliances and other arrangements with companies in the same or different industries in mind, we aim to address the diverse needs of medical institutions, make effective use of personnel and improve the efficiency of internal administrative operations by sharing back-office functions, and strengthen our competitiveness in regional markets.」
The company outlined a plan, based on capital alliances and other arrangements, to address the needs of medical institutions, share back-office functions, improve administrative efficiency, and strengthen regional competitiveness.